News

Share
22nd July 2021
12:22pm BST

The study published in the New England Journal of Medicine showed that two doses of Pfizer proved to be 88% effective against Delta, preventing symptomatic illness, compared to it being 93.7% effective against the Alpha variant.
When it comes to AstraZeneca, it proved to be 67% effective against the Delta variant, where it is 74.5% effective against the Alpha variant. It was originally estimated to be 66% effective.
"Only modest differences in vaccine effectiveness were noted with the Delta variant as compared with the Alpha variant after the receipt of two vaccine doses," Public Health England researchers wrote in the study.
Public Health England has said that only one dose of either vaccine proves to only be around 33% effective from the Delta variant, with Pfizer being 36% and AstraZeneca being around 30% effective.
"Our finding of reduced effectiveness after the first dose would support efforts to maximise vaccine uptake with two doses among vulnerable groups in the context of circulation of the Delta variant," the study said.
Like these vaccines, the one-shot Johnson & Johnson is also less effective against the Delta variant, according to a study by bioRxiv, but the exact figures have not been released yet.Explore more on these topics: